In this episode of Spread Love in Organizations, Sophie Kornowski reflects on a remarkable leadership journey spanning global pharmaceutical companies, biotech, investing, and entrepreneurship. From her early days in diagnostics during the AIDS epidemic to leading Boston Pharmaceuticals through its successful transformation and acquisition, she shares how both inspiring mentors and difficult setbacks shaped her leadership philosophy. Sophie explains why great leadership is built through continuous learning, self-awareness, and staying close to the people doing the work, while creating an environment where teams feel supported, challenged, and accountable.
The conversation explores what it takes to build and lead successful biotech organizations in today’s demanding environment. Sophie shares the principles that guided Boston Pharmaceuticals: identifying where true value lies, committing to a clear strategy without drifting, and remaining flexible in execution without losing sight of the mission. She discusses balancing empowerment with accountability, making courageous decisions amid uncertainty, and why exceptional companies combine a differentiated scientific vision with outstanding execution, commercial thinking, and teams that are willing to question assumptions and keep learning.
Looking ahead, Sophie offers an optimistic perspective on the future of healthcare innovation, highlighting major opportunities in metabolic disease, oncology, and immunology while emphasizing that improving patient health remains the industry’s ultimate purpose. In a memorable reflection on leadership, she describes leadership as “friendship,” explaining that trust, psychological safety, and genuine human connection give people the courage to speak up, innovate, and achieve extraordinary results. She closes with a powerful reminder for leaders navigating uncertainty: stay the course, keep learning, and maintain open, honest dialogue with your teams and boards.
“If people feel they are not in danger, they will have courage. They will be creative. They will speak up.”

MEET OUR GUEST Sophie Kornowski, CEO Sophiekor Insights.
Sophie Kornowski is a long-time biotech and pharmaceutical executive and now the CEO of Sophiekor Insights.
Prior to this role, Sophie served as Chief Executive Officer and Chair of the Board of Boston Pharmaceuticals, where she led a remarkable transformation of the company, culminating in its successful acquisition by GSK in 2025 for up to 2 billion dollars. Before that, Sophie was a Partner at Gurnet Point Capital, a private investment firm focused on healthcare, where she was a successful investor in several innovative start-ups and high-growth businesses developing and commercializing products across areas including ADHD, cancer, and food allergy. Earlier in her career, Sophie was Executive Vice President of Partnering at Roche and a member of the Extended Corporate Executive Committee of F. Hoffmann-La Roche, as well as a board member of Chugai Pharmaceutical. In that role, working closely with the R&D and commercial teams at Roche and Genentech, she led global partnering and M&A strategy across biotech, pharma, health tech, and research institutions worldwide.
Previously, Sophie also led Roche’s largest affiliate outside the United States, based in France, for many years.
EPISODE TRANSCRIPT: Sophie Kornowski
Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose. I’m Naji, your host, and I’m delighted to be joined today by Sophie Kornowski, a long-time biotech and pharmaceutical executive and now the CEO of Sophiecore Insights. Prior to this role, Sophie served as Chief Executive Officer and Chair of the Board of Boston Pharmaceuticals, where she led a remarkable transformation of the company, culminating in its successful acquisition by GSK in 2025 for up to 2 billion dollars. Before that, Sophie was a Partner at Gurnet Point Capital, a private investment firm…





























































































































































































